Pfizer's CEO Albert Bourla told shareholders at its annual meeting in April that it is comfortable the firm will produce 3 billion doses of the vaccine in 2021 and will further invest in its manufacturing network to support continued global demand. Image: iStock/Bigandt_Photography Part of its further investment in its manufacturing network is being plugged into Ireland where Pfizer will devote up to $40 million at its Grange Castle, Dublin facility to produce the COVID-19 vaccine. "Pfizer is now bringing on additional European-based facilities to be a part of the global Pfizer-BioNTech COVID-19 Vaccine supply chain network and Grange Castle (Ireland) will contribute to the worldwide supply of the vaccine," a spokeswoman for Pfizer told BioProcess Insider. She added: "Pfizer's Grange Castle facility will produce mRNA drug substance.